Visit us at Clinical Trial Supply Europe 2026
Whether your investigational drug is a small molecule, large molecule, or advanced therapy, we provide valuable support at every touchpoint to help streamline your supply chain.
February 24–25, 2026 | Barcelona, Spain | Booth #3
About CTS Europe 2026
The 27th annual conference returns to Barcelona in 2026, once again serving as the premier meeting place for the biopharma community. Attendees will gain valuable insights, build meaningful connections, and explore how to advance clinical supply strategy for the future.
This year, large and small pharma organizations, alongside emerging biotechs, will have dedicated opportunities to discuss, debate, and evaluate emerging technologies and processes designed to streamline supply chain operations and drive long-term success in drug development.
Visit Thermo Fisher Scientific’s team at booth #3 to connect with our experts and learn how our end-to-end, integrated CDMO and CRO capabilities can bolster the success of your research studies, ultimately supporting your aspiration to get treatments to patients faster.
Event details
Date: February 24-25, 2026
Format: In person
Location: Barcelona, Spain
Booth number: #3
Event website:
27th Annual Clinical Trial Supply Europe 2026 - Arena International
Why Thermo Fisher Scientific?
Our comprehensive clinical trial capabilities are powered by a dedicated team of drug development experts committed to supporting the unique needs of sponsors conducting clinical research.
With more than 30 years of industry-leading experience, we help biotech and pharma companies build robust, resilient supply chains that can withstand external pressures and evolving demands.
Visit booth #3 to meet our experts and discover how our integrated CDMO and CRO offerings—and our strategic supply solutions—can support your trial needs, regardless of its size or scope.
Attend our expert-led session:
“Confidence in clinical supply: Keeping trials on track”
- Stream B: Clinical Supply Technology & Innovation (30 minutes)
- Date: Wednesday, February 25 at 10:30 a.m. CET
- Speaker: Mergime Behrami, Senior Manager, Sales EMEA Biotech
Drug development is advancing in an environment shaped by regulatory change, geopolitical pressure, and increasing operational complexity. For biotechnology organizations running global and adaptive trials, maintaining clinical supply continuity has become essential to sustaining momentum and reducing risk on the journey to market.
In this session, Mergime Behrami will examine how confidence in clinical supply is built through readiness, scale, and operational foresight. Drawing on real-world experience across regions and modalities, she’ll explore how stable infrastructure and adaptable execution help keep trials moving with greater predictability as conditions evolve.
Key takeaways:
- How end-to-end clinical supply control and a globally distributed network support continuity across complex trial designs and geographies
- Practical approaches to managing trade, tariff, and compliance risk through proactive planning and regional operating models
- How applied AI and automation in clinical supply operations are improving quality, efficiency, and reliability while maintaining regulatory control
Find your missing element at booth #3
Discover the difference of a clinical trial services partner with the coordination to streamline your supply chain and the diligence to see your study through to success.
Visit booth #3 to explore our range of services and solutions, including:
- Clinical label design and translation management
- Strategic comparator and co-medication sourcing
- Biorepository storage, distribution, and logistics
We look forward to meeting you in person.
Continuing education for the pharma industry
Follow us on social for event updates
We look forward to seeing you soon